DEFINITION
Yttrium Y90 Ibritumomab Tiuxetan

An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Also called IDEC-Y2B8.

Loading conversations.
Similar or Related Terms
Statistics
179
Characters
33
Words
43.39
Flesch Reading Ease
9.9
Flesch Kincaid Grade